Control of microglial neurotoxicity by the fractalkine receptor
The DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.
Abstract
Microglia, the resident inflammatory cells of the CNS, are the only CNS cells that express the fractalkine receptor (CX3CR1). Using three different in vivo models, we show that CX3CR1 deficiency dysregulates microglial responses, resulting in neurotoxicity. Following peripheral lipopolysaccharide injections, Cx3cr1-/- mice showed cell-autonomous microglial neurotoxicity. In a toxic model of Parkinson disease and a transgenic model of amyotrophic lateral sclerosis, Cx3cr1-/- mice showed more extensive neuronal cell loss than Cx3cr1+ littermate controls. Augmenting CX3CR1 signaling may protect against microglial neurotoxicity, whereas CNS penetration by pharmaceutical CX3CR1 antagonists could increase neuronal vulnerability.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Microglia were labeled using the CX3CR1+/GFP mouse line in which all microglia express EGFP under the control of fractalkine receptor, CX3CR1, expression (Figure 1, S1, and S5) (Cardona et al., 2006; Jung et al., 2000; Saederup et al., 2010).”
From Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner (2012) · cites this paper as Cardona et al., 2006
In the citing paper
“microglia are uniformly CX3CR1+ from early embryonic time points through adulthood (Cardona et al., 2006; Ginhoux et al., 2010; Schulz et al., 2012)”
From Differential roles of microglia and monocytes in the inflamed central nervous system (2014) · cites this paper as Cardona et al., 2006
In the citing paper
“Conflicting evidence in the literature suggests either neurotoxic or neuroprotective effects of CX3CR1 deletion in various disease models (Cardona et al., 2006; Fuhrmann et al., 2010).”
From CX3CR1 in Microglia Regulates Brain Amyloid Deposition through Selective Protofibrillar Amyloid-β Phagocytosis (2010) · cites this paper as Cardona et al., 2006
In the citing paper
“Our findings support the concept that fractalkine through its receptor CX3CR1 (Harrison et al., 1998) acts as a repressor of microglia activation (Cardona et al., 2006).”
From CX3CR1 in Microglia Regulates Brain Amyloid Deposition through Selective Protofibrillar Amyloid-β Phagocytosis (2010) · cites this paper as Cardona et al., 2006
In the citing paper
“While CX3CR1 is expressed by many leukocyte cell types in the periphery, 15 in the brain CX3CR1 is exclusively expressed by microglia 13 whereas CX3CL1 is highly expressed within neurons.14”
From CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models (2010) · cites this paper as [13]
15 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827 · cited 1×
“Microglia, which have characteristics of immature myeloid cells, sample the extracellular space of the healthy CNS through continuous extension, retraction and remodeling of cellular processe”
BackgroundMicroglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396 · cited 1×
“In response to injury, microglial cells undergo rapid morphological and functional activation and acquire properties of mature myeloid cells, including antigen presentation, reactive species generation, matrix metalloproteinase (MMP) expression and phagocytosis, as well as cytokine and growth factor secretio”
BackgroundATP mediates rapid microglial response to local brain injury in vivo
Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., Littman, D. R., Dustin, M. L., & Gan, W.-B. (2005) · Nature Neuroscience · doi:10.1038/nn1472 · Cited by 3,913 · cited 1×
“Microglia, which have characteristics of immature myeloid cells, sample the extracellular space of the healthy CNS through continuous extension, retraction and remodeling of cellular processe”
BackgroundSelf-citationBlood Monocytes Consist of Two Principal Subsets with Distinct Migratory Properties
Geissmann, F., Jung, S., & Littman, D. R. (2003) · Immunity · doi:10.1016/s1074-7613(03)00174-2 · Cited by 3,391 · cited 1×
“However, peripheral immune and inflammatory reactions are mostly unaltered in Cx3cr1 −/− or Cx3cl1 −/− mic”
BackgroundSelf-citationJung, S., Aliberti, J., Graemmel, P., Sunshine, M. J., Kreutzberg, G. W., Sher, A., & Littman, D. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.4106-4114.2000 · Cited by 2,632
Self-citationThe many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523 · cited 1×
“Based on these and other findings, efforts to develop pharmacological inhibitors of CX3CR1 are in progres”
BackgroundSelf-citationCX 3 CR1-Mediated Dendritic Cell Access to the Intestinal Lumen and Bacterial Clearance
Niess, J. H., Brand, S., Gu, X., Landsman, L., Jung, S., McCormick, B. A., Vyas, J. M., Boes, M., Ploegh, H. L., Fox, J. G., et al. (2005) · Science · doi:10.1126/science.1102901 · Cited by 1,611 · cited 2×
“Targeted deletion of CX(3)CR1 reveals a role for fractalkine in cardiac allograft rejection.”
BackgroundSelf-citationMicroglia-specific localisation of a novel calcium binding protein, Iba1
Ito, D., Imai, Y., Ohsawa, K., Nakajima, K., Fukuuchi, Y., & Kohsaka, S. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00040-0 · Cited by 1,476 · cited 1×
“Results Neuronal damage in Cx3cr1 −/− mice after systemic LPS We first examined the GFP + population in the CNS of Cx3cr1 GFP mice and found that green fluorescent cells overlapped precisely with brain cells expressing microglial markers such as ionized calcium-binding adapter molecule-1 (IBA-1”
BackgroundHarrison, J. K., Jiang, Y., Chen, S., Xia, Y., Maciejewski, D., McNamara, R. K., Streit, W. J., Salafranca, M. N., Adhikari, S., Thompson, D. A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10896 · Cited by 1,176 · cited 1×
“dtd" [ ]> CX3CR1 is expressed by monocytes, dendritic cells (DCs), and subsets of T cells and natural killer cells in the circulation and by microglia in the central nervous system (CNS”
Takahashi, K., Rochford, C. D. P., & Neumann, H. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041611 · Cited by 1,124 · cited 1×
“Knockdown of TREM2 in mouse microglia impairs their phagocytic activity and enhances inflammatory gene expression, suggesting a mechanism for the human disorde”
Background
Cited by
Items 601–700 of 1,003
Lana, D., Ugolini, F., Nosi, D., Wenk, G. L., & Giovannini, M. G. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.651973 · Cited by 69
“Membrane bound CX3CL1 is an adhesion molecule, while its cleaved, soluble form, is a chemoattractant that recruits microglia that express its receptor (CX3CR1) to injured neurons (Harrison et al., 1998; Chapman et al., 2000; Cardona et al., 2006; Noda et al., 2011).”
BackgroundL. Hebron, M. (2014) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000259 · Cited by 68
“Exogenous CX3CL1 is neuro-protective in some models of neuro-inflammation [94,95], and disruption of CX3CL1 signaling causes neurotoxicity in models of systemic inflammation, PD, and amyotrophic lateral sclerosis [96] but protects against neuronal loss in a mouse model of focal cerebral ischemia [97].”
BackgroundParillaud, V. R., Lornet, G., Monnet, Y., Privat, A.-L., Haddad, A. T., Brochard, V., Bekaert, A., de Chanville, C. B., Hirsch, E. C., Combadière, C., et al. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0830-9 · Cited by 70
“As reported before [30], we confirmed increased DA neuronal loss in single CX3CR1 deleted mice (CX3CR1) when compared to wild-type mice (46% loss compared to 26%) (Fig.”
BackgroundInfluentialPattarini, R., Smeyne, R. J., & Morgan, J. I. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.12.030 · Cited by 73
The Interplay of MicroRNAs in the Inflammatory Mechanisms Following Ischemic Stroke
Khoshnam, S. E., Winlow, W., & Farzaneh, M. (2017) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlx036 · Cited by 75
“Thus, loss of fractalkine following neuronal injury leads to increased microglial activation in several inflammatory conditions (163).”
BackgroundSosa, R. A., Murphey, C., Ji, N., Cardona, A. E., & Forsthuber, T. G. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300771 · Cited by 68
Self-citationHertwig, L., Hamann, I., Romero‐Suarez, S., Millward, J. M., Pietrek, R., Chanvillard, C., Stuis, H., Pollok, K., Ransohoff, R. M., Cardona, A. E., et al. (2016) · European Journal of Immunology · doi:10.1002/eji.201546194 · Cited by 68
Self-citationMo, Z., Zeng, Z., Liu, Y., Zeng, L., Fang, J., & Ma, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.914537 · Cited by 77
Microglial Activation and Priming in Alzheimer’s Disease: State of the Art and Future Perspectives
Bivona, G., Iemmolo, M., Agnello, L., Sasso, B. L., Gambino, C. M., Giglio, R. V., Scazzone, C., Ghersi, G., & Ciaccio, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24010884 · Cited by 79
Thome, A. D., Standaert, D. G., & Harms, A. S. (2015) · PLOS ONE · doi:10.1371/journal.pone.0140566 · Cited by 68
“In an 1-methyl-4-phenyl1,2,3,6-tetrahydropyridine (MPTP) neurotoxin model of PD, CX3CR1 knockout exacerbated inflammation and neurodegeneration [22].”
BackgroundInfluentialModulation of connexin 43 in rotenone-induced model of Parkinson's disease
Kawasaki, A., Hayashi, T., Nakachi, K., Trosko, J. E., Sugihara, K., Kotake, Y., & Ohta, S. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.01.080 · Cited by 75
Chen, M., Zhao, J., Luo, C., Pandi, S. P. S., Penalva, R. G., Fitzgerald, D. C., & Xu, H. (2012) · Glia · doi:10.1002/glia.22315 · Cited by 67
“The chemokine CX3CL1 (also called fracktalkine) binds to the receptor CX3CR1, which is expressed predominately by resident microglial cells in the CNS and retina (Cardona et al., 2006; Kezic et al., 2008).”
BackgroundKomada, M., Hara, N., Kawachi, S., Kawachi, K., Kagawa, N., Nagao, T., & Ikeda, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-04289-1 · Cited by 71
Divergent Effects of Metformin on an Inflammatory Model of Parkinson’s Disease
Tayara, K., Espinosa‐Oliva, A. M., García-Domínguez, I., Ismaiel, A. A., Boza‐Serrano, A., Deierborg, T., Machado, A., Herrera, A. J., Venero, J. L., & de Pablos, R. M. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00440 · Cited by 71
“Still, activation of CX3CR1 has been related to a decrease in the neurotoxic actions of microglia (Cardona et al., 2006); (b) CD200/CD200R, which attenuates microglia activation especially under inflammatory conditions (Barclay et al.”
MacDowell, K. S., Munarriz‐Cuezva, E., Caso, J. R., Madrigal, J. L. M., Zabala, A., Meana, J. J., García‐Bueno, B., & Leza, J. C. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.12.025 · Cited by 79
“…been found that it also exerts an in vivo regulatory role of microglial neurotoxicity (mediated by M1 phenotype), thereby inducing the M2 phenotype and promoting neuroprotection and neuronal survival in murine models of amyotrophic lateral sclerosis and Parkinson's disease (Cardona et al., 2006).”
BackgroundValera, E., Mante, M., Anderson, S., Rockenstein, E., & Masliah, E. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0320-x · Cited by 66
“In a model of PD, the lack of fractalkine receptor results in exacerbation of neuronal cell death and increased production and release of IL-1β by microglia [39].”
BackgroundScianni, M., Antonilli, L., Chece, G., Cristalli, G., Di Castro, M. A., Limatola, C., & Maggi, L. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-108 · Cited by 66
“Since CX3CR1 is expressed on microglial cells [5,6], we wondered whether microglial activation was required for CX3CL1-mediated STP of NMDA-fEPSPs.”
BackgroundSun, H., Bénardais, K., Stanslowsky, N., Thau-Habermann, N., Hensel, N., Huang, D., Claus, P., Dengler, R., Stangel, M., & Petri, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072926 · Cited by 66
“Another study showed that enhancing CX3CR1 expression protects against microglial neurotoxicity [69].”
BackgroundSelf-citationMicroglia Mediate HIV-1 gp120-Induced Synaptic Degeneration in Spinal Pain Neural Circuits
Ru, W., Liu, X., Bae, C., Shi, Y., Walikonis, R. S., Chung, J. M., & Tang, S. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.2851-18.2019 · Cited by 69
“CX3CR1 (a receptor of FKN) is exclusively expressed on microglia in the CNS, whereas FKN is specifically addressed in neurons (Harrison et al., 1998; Cardona et al., 2006; Ransohoff, 2009).”
BackgroundZhang, J., Liu, Y., Liu, X., Li, S., Cheng, C., Chen, S., & Le, W. (2018) · Translational Neurodegeneration · doi:10.1186/s40035-018-0138-4 · Cited by 57
B Cells in Neuroinflammation: New Perspectives and Mechanistic Insights
Ahn, J. J., Abu-Rub, M., & Miller, R. H. (2021) · Cells · doi:10.3390/cells10071605 · Cited by 69
Church, K. A., Rodriguez, D., Vanegas, D., Gutiérrez, I. L., Cardona, S. M., Madrigal, J. L. M., Kaur, T., & Cardona, A. E. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02659-9 · Cited by 75
“The following cell subsets were identified using the previously stated cocktail: neutrophils (CD45HiCD11b+SSCHi), tissue resident (CD45HiCD11b+Ly6CLo) and inflammatory (CD45HiCD11b+Ly6CHi) macrophages, myeloid-derived (CD45HiCD11b+CD11c+) dendritic cells (DCs), conventional DCs (CD45HiCD11b–CD11c+), CNS-resident micro…”
MethodSelf-citationCX 3 CR1 deficiency delays acute skeletal muscle injury repair by impairing macrophage functions
Zhao, W., Lu, H., Wang, X., Ransohoff, R. M., & Zhou, L. (2016) · The FASEB Journal · doi:10.1096/fj.14-270090 · Cited by 65
“CX3CR1 deficiency affected outcomes of many experimental disease and injury models, including arthrosclerosis (18, 19), spinal cord injury (14), acute colitis (17), infectious peritonitis (16), dermal wound repair (12, 15), ototoxic injury (20), experimental autoimmune encephalomyelitis (EAE) (21), acute ischemic stro…”
BackgroundSelf-citationAnderson, A. M. L., Harezlak, J., Bharti, A., Mi, D., Taylor, M. J., Daar, E. S., Schifitto, G., Zhong, J., Alger, J. R., Brown, M. S., et al. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000532 · Cited by 65
“FKN (CX3CL1) is produced by neurons and has neuroprotective properties that were evident in the BG.(12,39) Here, FKN was the only biomarker that was associated with better NAA/Cr levels.”
InfluentialCX3CL1/CX3CR1 in Alzheimer’s Disease: A Target for Neuroprotection
Chen, P., Zhao, W., Guo, Y., Xu, J., & Yin, M. (2016) · BioMed Research International · doi:10.1155/2016/8090918 · Cited by 64
“This also has been confirmed that disruption of CX3CL1-CX3CR1 leads to dysregulate microglial responses and neuronal damage [12, 18].”
BackgroundHow to Get from Here to There: Macrophage Recruitment in Alzheimers Disease
Rezai-Zadeh, K., Gate, D., Gowing, G., & Town, T. (2011) · Current Alzheimer Research · doi:10.2174/156720511795256017 · Cited by 64
“In the MPTP intoxication model of PD and in a transgenic mouse model of ALS, Cx3cr1−/− mice demonstrated increased neuronal cell loss compared to Cx3cr1sufficient littermate controls [71].”
BackgroundNeuroimmune Response in Ischemic Preconditioning
McDonough, A., & Weinstein, J. R. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0465-z · Cited by 67
“[127], suggesting CB1 receptors may be a potential therapeutic target for preconditioning.”
BackgroundMidbrain microglia mediate a specific immunosuppressive response under inflammatory conditions
Abellanas, M. A., Zamarbide, M., Basurco, L., Luquin, E., Garcia-Granero, M., Clavero, P., San Martin-Uriz, P., Vilas, A., Mengual, E., Hervas-Stubbs, S., et al. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1628-8 · Cited by 64
Angelopoulou, E., Paudel, Y. N., Shaikh, M. F., & Piperi, C. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104930 · Cited by 69
S100A8/A9 Drives Neuroinflammatory Priming and Protects against Anxiety-like Behavior after Sepsis
Denstaedt, S. J., Spencer-Segal, J. L., Newstead, M. W., Laborc, K. F., Zhao, A. P., Hjelmaas, A., Zeng, X., Akil, H., Standiford, T. J., & Singer, B. H. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1700834 · Cited by 67
Crespo-Castrillo, A., & Arevalo, M.-A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093219 · Cited by 63
Winter, A. N., Subbarayan, M. S., Grimmig, B. A., Weesner, J. A., Moss, L. D., Peters, M. M., Weeber, E. J., Nash, K. R., & Bickford, P. C. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01828-y · Cited by 66
Natural killer cells associate with amyotrophic lateral sclersois in a sex- and age-dependent manner
Murdock, B. J., Famie, J. P., Piecuch, C. E., Raue, K. D., Mendelson, F. E., Pieroni, C. H., Iniguez, S. D., Zhao, L., Goutman, S. A., & Feldman, E. L. (2021) · JCI Insight · doi:10.1172/jci.insight.147129 · Cited by 49
“These results are consistent with a previous study that found that the deletion of CX3CR1 in the microglia of ALS mice accelerated disease, but only in male mice (34).”
Pesticides, Microglial NOX2, and Parkinson's Disease
Taetzsch, T., & Block, M. L. (2013) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.21464 · Cited by 63
Neuron-Microglia Dialogue and Hippocampal Neurogenesis in the Aged Brain.
Gemma, C., Bachstetter, A. D., & Bickford, P. C. (2010) · Europe PMC (PubMed Central) · Cited by 74
Microglial Function and Regulation during Development, Homeostasis and Alzheimer’s Disease
Casali, B. T., & Reed-Geaghan, E. G. (2021) · Cells · doi:10.3390/cells10040957 · Cited by 78
“Some homeostatic receptors provide known inhibitory signaling, as is the case with CX3CR1 and its cognate neuronal ligand CX3CL1, which provides protection against microglialmediated neurotoxicity [47].”
BackgroundWang, Y., Fu, Y., Xue, S., Ai, A., Chen, H., Lyu, Q., & Kuang, Y. (2014) · Europe PMC (PubMed Central) · Cited by 62
Wu, J., Bie, B., Yang, H., Xu, J. J., Brown, D. L., & Naguib, M. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.06.003 · Cited by 64
“This immunoreactivity of CX3CR1 was colocalized with that of CD11b as previously reported (Cardona et al., 2006; Cho et al., 2011), confirming the exclusive localization of CX3CR1 in the central microglia (Fig.”
BackgroundResultInfluentialSuppressed pro-inflammatory response of microglia in CX3CR1 knockout mice
Mattison, H. A., Nie, H., Gao, H., Zhou, H., Hong, J.-S., & Zhang, J. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.02.008 · Cited by 62
“Although a neuroprotective role for CX3CL1-CX3CR1 signaling has been supported in studies of CX3CR1-deficient mouse models of amyotrophic lateral sclerosis (ALS), PD (Cardona et al., 2006), and multiple sclerosis (MS) (Huang et al.”
BackgroundResultInfluentialFan, Q., He, W., Gayen, M., Benoit, M. R., Luo, X., Hu, X., & Yan, R. (2020) · The Journal of Neuroscience · doi:10.1523/jneurosci.1333-19.2019 · Cited by 58
“, 2014) and to increase neurodegeneration (Cardona et al., 2006).”
BackgroundXu, M.-X., Yu, R., Shao, L.-F., Zhang, Y.-X., Ge, C.-X., Liu, X.-M., Wu, W.-Y., Li, J.-M., & Kong, L.-D. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.01.001 · Cited by 61
“The absence of CX3CR1 is associated with a worse outcome in neurodegenerative disorders, possibly due to the lack of FKN control during microglial activation, subsequently, being a proinflammatory state (Cardona et al., 2006; Cipriani et al., 2011; Paolicelli et al., 2014).”
BackgroundWang, S. K., Xue, Y., Rana, P., Hong, C. M., & Cepko, C. L. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901787116 · Cited by 60
Fernández‐Albarral, J. A., Salazar, J. J., de Hoz, R., Marco, E. M., Martín‐Sánchez, B., Flores-Salguero, E., Salobrar‐García, E., López‐Cuenca, I., Barrios, V., Avilés‐Trigueros, M., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042066 · Cited by 63
Fletcher, E. L., Downie, L. E., Hatzopoulos, K. M., Vessey, K. A., Ward, M. M., Chow, C., Pianta, M. J., Vingrys, A. J., Kalloniatis, M., & Wilkinson‐Berka, J. L. (2009) · Documenta Ophthalmologica · doi:10.1007/s10633-009-9193-6 · Cited by 64
“, Ccl2 null mice, CX3CR1 null mice; [86, 87, 92].”
Interactions between Chemokines
Cook, A., Hippensteel, R., Shimizu, S., Nicolai, J., Fatatis, A., & Meucci, O. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.035477 · Cited by 64
Targeting the Cancer-Stroma Interaction: A Potential Approach for Pancreatic Cancer Treatment
Li, X., Ma, Q., Xu, Q., Duan, W., Lei, J., & Wu, E. (2012) · Current Pharmaceutical Design · doi:10.2174/13816128112092404 · Cited by 61
Hypothalamic mitochondrial abnormalities occur downstream of inflammation in diet-induced obesity
Carraro, R. S., Souza, G. F., Solon, C., Razolli, D. S., Chausse, B., Barbizan, R., Victorio, S. C., & Velloso, L. A. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.07.029 · Cited by 54
“Fractalkine is a chemokine involved in the recruitment of bone marrow-derived monocytes to inflammation sites (Cardona et al., 2006).”
BackgroundMatarredona, E. R., Talaverón, R., & Pastor, Á. M. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00268 · Cited by 68
GPR34 in spinal microglia exacerbates neuropathic pain in mice
Sayo, A., Konishi, H., Kobayashi, M., Kano, K., Kobayashi, H., Hibi, H., Aoki, J., & Kiyama, H. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1458-8 · Cited by 64
Ross, R. J., Zhou, M., Shen, D., Fariss, R. N., Ding, X., Bojanowski, C. M., Tuo, J., & Chan, C.-C. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.01.014 · Cited by 60
Shukla, A. K., McIntyre, L. L., Marsh, S. E., Schneider, C. A., Hoover, E. M., Walsh, C. M., Lodoen, M. B., Blurton‐Jones, M., & Inlay, M. A. (2019) · Glia · doi:10.1002/glia.23575 · Cited by 60
“The fractalkine receptor Cx3cr1, is strongly expressed by microglia in the CNS and has been crucial in studying microglia development and functions in homeostatic and neuroinflammatory conditions (Cardona et al., 2006; Jung et al., 2000; Mizutani et al., 2012).”
BackgroundGlial smog: Interplay between air pollution and astrocyte-microglia interactions
Gómez‐Budia, M., Konttinen, H., Saveleva, L., Korhonen, P., Jalava, P., Kanninen, K. M., & Malm, T. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104715 · Cited by 63
Neuroinflammation in retinitis pigmentosa: Therapies targeting the innate immune system
Zhao, L., Hou, C., & Yan, N. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1059947 · Cited by 75
IL-4/10 prevents stress vulnerability following imipramine discontinuation
Han, A., Yeo, H., Park, M.-J., Kim, S. H., Choi, H. J., Hong, C.-W., & Kwon, M.-S. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0416-3 · Cited by 60
“CX3CR1 plays a crucial role in regulating neurotoxicity of microglia, and its stimulation was found to be anti-inflammatory [62, 63].”
BackgroundExpression, transport, and axonal sorting of neuronal CCL21 in large dense‐core vesicles
de Jong, E. K., Vinet, J., Stanulovic, V. S., Meijer, M., Wesseling, E., Sjollema, K., Boddeke, H. W. G. M., & Biber, K. (2008) · The FASEB Journal · doi:10.1096/fj.07-101907 · Cited by 59
Rosito, M., Lauro, C., Chece, G., Porzia, A., Monaco, L., Mainiero, F., Catalano, M., Limatola, C., & Trettel, F. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00193 · Cited by 60
Chemokines in Alzheimer’s Disease: New Insights Into Prokineticins, Chemokine-Like Proteins
Zuena, A. R., Casolini, P., Lattanzi, R., & Maftei, D. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00622 · Cited by 60
“CX3CR1 is also partly expressed in astrocytes and neurons (Meucci et al., 2000; Cardona et al., 2006), suggesting that CX3CL1/CX3CR1 pathway plays a major role in neuron/ microglia communication and allows neurons to regulate microglia activation (Limatola and Ransohoff, 2014).”
BackgroundVagus nerve stimulation modulates hippocampal inflammation caused by continuous stress in rats
Namgung, U., Kim, K.-J., Jo, B.-G., & Park, J.-M. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02396-z · Cited by 59
“It will be of great interest to determine whether VNS modulates the effects of fractalkine–CX3CR1 signaling for the regulation of microglial neurotoxicity in the hippocampus of CS animals [45].”
BackgroundAged Microglia in Neurodegenerative Diseases: Microglia Lifespan and Culture Methods
Yoo, H.-J., & Kwon, M. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.766267 · Cited by 94
Immune and behavioral consequences of microglial reactivity in the aged brain
Wynne, A. M., Henry, C. J., & Godbout, J. P. (2009) · Integrative and Comparative Biology · doi:10.1093/icb/icp009 · Cited by 59
“For example, CX3CR1deficient mice (CX3CR1 –/– mice) exhibited enhanced microglial activation after repeated intraperitoneal LPS injection, which was also associated with microglial-mediated neurotoxicity (Cardona et al. 2006).”
BackgroundSiddiqui, T. A., Lively, S. S., & Schlichter, L. C. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0531-9 · Cited by 67
“In the CNS, CX3CR1 is expressed exclusively by microglia and perivascular macrophages [48] and is required for effective clearance of myelin debris [49].”
BackgroundThe Role of Microglia in Prion Diseases: A Paradigm of Functional Diversity
Obst, J., Simon, E., Mancuso, R., & Gómez‐Nicola, D. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00207 · Cited by 63
“The neurotoxicity induced by activated microglia in neurodegenerative diseases seems to be worsened in CX3CR1-deficient mice, suggesting that the signaling through CX3CL1/CX3CR1 regulates the phenotype of microglia (Cardona et al., 2006).”
BackgroundDifferential Modulation of Retinal Degeneration by Ccl2 and Cx3cr1 Chemokine Signalling
Luhmann, U. F. O., Lange, C. A., Robbie, S., Munro, P. M. G., Cowing, J. A., Armer, H. E. J., Luong, V., Carvalho, L. S., MacLaren, R. E., Fitzke, F. W., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035551 · Cited by 58
“Therefore, we hypothesise that the additional neurotoxic effect of Cx3cr1 deficiency on the retinal degeneration caused by the Crb1 mutation might be due to an impaired migratory capability and a subsequent reduced removal of dying photoreceptors by Cx3cr1deficient microglia which might result in the production of mor…”
BackgroundGenetic manipulation of microglia during brain development and disease
Wieghofer, P., & Prinz, M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.09.019 · Cited by 61
Neural Stem Cell-Based Regenerative Approaches for the Treatment of Multiple Sclerosis
Xiao, J., Yang, R., Biswas, S., Zhu, Y., Qin, X., Zhang, M., Zhai, L., Luo, Y., He, X., Mao, C., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0566-7 · Cited by 62
“For example, NSCs can induce a significant upregulation of the surface molecules CX3CR1 on microglia which is associated with a neuroprotective phenotype [123] and triggering receptor expressed on myeloid cells-2 (TREM2) [124].”
BackgroundCardona, S. M., Kim, S. V., Church, K. A., Torres, V. O., Cleary, I. A., Mendiola, A. S., Saville, S. P., Watowich, S. S., Parker‐Thornburg, J., Soto-Ospina, A., et al. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00365 · Cited by 61
“Due to the expression of IL-1 related transcripts and the association of IL-1β with microglial neurotoxicity (Cardona et al., 2006) we assessed protein expression by staining and tissue ELISA and found that soluble IL-1β is higher in WT tissues with expression likely restricted to infiltrating immune cells, whereas in…”
BackgroundMethodSelf-citationMa, B., Xu, L., Pan, X., Sun, L., Ding, J., Xie, C., Koliatsos, V. E., & Cai, H. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw194 · Cited by 56
“Genetic disruption of Cx3cr1 causes excessive microglial activation, resulting in neurotoxicity in mouse models of systemic inflammation, PD, and amyotrophic lateral sclerosis (8).”
BackgroundResultMendiola, A. S., Garza, R., Cardona, S. M., Mythen, S. A., Lira, S. A., Akassoglou, K., & Cardona, A. E. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00303 · Cited by 56
“Induction of Systemic Inflammation via Lipopolysaccharide Injections Acute endotoxemia (systemic inflammation) was established as previously described (Cardona et al., 2006; Chen et al., 2012).”
BackgroundMethodSelf-citationGonçalves, J., Leitão, R. A., Higuera‐Matas, A., Assis, M. A., Coria, S. M., Ribeiro, C., Ambrosio, E., & Silva, A. P. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.02.017 · Cited by 63
Kaur, T., Ohlemiller, K. K., & Warchol, M. E. (2017) · The Journal of Comparative Neurology · doi:10.1002/cne.24369 · Cited by 62
“Similarly, studies in the CNS have reported enhanced neurotoxicity and inflammation in mice lacking CX3CR1 in models of low-endotoxemia, Parkinson’s disease, Amyotrophic lateral sclerosis, and Diabetic retinopathy (Cardona et al., 2006, 2015).”
BackgroundInfluentialPrimiani, C. T., Ryan, V. H., Rao, J. S., Cam, M. C., Ahn, K., Modi, H. R., & Rapoport, S. I. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110972 · Cited by 56
“CX3CR1 is expressed exclusively by microglia in brain [90], whereas CX3CL1 is highly expressed in neurons.”
BackgroundMicroglia as therapeutic target in central nervous system disorders
Fatoba, O., Itokazu, T., & Yamashita, T. (2020) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2020.07.004 · Cited by 61
Capuccini, B., Lin, J., Talavera-López, C., Khan, S. M., Sodenkamp, J., Spaccapelo, R., & Langhorne, J. (2016) · Scientific Reports · doi:10.1038/srep39258 · Cited by 56
How Stress Shapes Neuroimmune Function: Implications for the Neurobiology of Psychiatric Disorders
Koo, J. W., & Wohleb, E. S. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.11.007 · Cited by 64
Yeo, S.-I., Kim, J.-E., Ryu, H. J., Seo, C. H., Lee, B. C., Choi, I.-G., Kim, D.-S., & Kang, T.-C. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.03.005 · Cited by 55
“, 2006), microglial neurotoxicity (Zujovic et al., 2000; Cardona et al., 2006) and neuron survival (Meucci et al.”
Gain in Brain Immunity in the Oldest-Old Differentiates Cognitively Normal from Demented Individuals
Katsel, P., Tan, W., & Haroutunian, V. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007642 · Cited by 55
“CX3CR1 null mice show more neuronal loss and cellautonomous microglial neurotoxicity than control mice[58] and DAP12/TYROBP [67] or associated receptor TREM2 [68] null mice show impaired phagocytic activity and enhanced inflammatory gene expression that is manifested in adult onset dementing leukoencephalopathy caused…”
BackgroundO’Sullivan, S. A., Gasparini, F., Mir, A. K., & Dev, K. K. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0659-7 · Cited by 59
“More specifically, sCX3CL1 has the capability of enhancing microglial response to CNS damage, thereby promoting a pro-inflammatory environment [69].”
BackgroundResultModulation of Neuroinflammation in the Central Nervous System: Role of Chemokines and Sphingolipids
Gualtierotti, R., Guarnaccia, L., Beretta, M., Navone, S. E., Campanella, R., Riboni, L., Rampini, P. M., & Marfia, G. (2017) · Advances in Therapy · doi:10.1007/s12325-016-0474-7 · Cited by 61
Spinal Cord Injury Impairs Neurogenesis and Induces Glial Reactivity in the Hippocampus
Jure, I., Pietranera, L., Nicola, A. F. D., & Labombarda, F. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2225-9 · Cited by 62
“In addition, fractalkine produced by neurons control the extent of neuroinflammation and protects neurons against microglia neurotoxicity in PD and ALS [63].”
BackgroundThe role of microglia in the progression of glaucomatous neurodegeneration- a review
Zeng, H.-L., & Shi, J. (2018) · International Journal of Ophthalmology · doi:10.18240/ijo.2018.01.22 · Cited by 65
Cell and molecular mechanisms behind diet‐induced hypothalamic inflammation and obesity
Ávalos, Y., Kerr, B., Maliqueo, M. A., & Dorfman, M. D. (2018) · Journal of Neuroendocrinology · doi:10.1111/jne.12598 · Cited by 55
Peralta Ramos, J. M., Iribarren, P., Bousset, L., Melki, R., Baekelandt, V., & Van der Perren, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00080 · Cited by 53
“Systemic injection of the endotoxin LPS has been widely used as an inflammatory model (8, 9).”
MethodCellular Contributors to Hypothalamic Inflammation in Obesity.
Lee, C. H., Suk, K., Yu, R., & Kim, M. (2020) · PubMed Central · doi:10.14348/molcells.2020.0055 · Cited by 67
“Consistent with this, CX3CR1 deficiency worsens neurodegeneration because of greater microglial-mediated neurotoxicity (Cardona et al., 2006).”
BackgroundLiu, C., Luo, D., Streit, W. J., & Harrison, J. K. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.04.016 · Cited by 56
“Enhanced neuronal cell loss is also evident in CX3CR1 deficient mice after systemic lipopolysaccharide injection, in toxin-induced Parkinsonism, and the SOD1G93A transgenic mouse model of motor neuron disease (Cardona et al., 2006).”
InfluentialÇalışkan, G., French, T., Lacalle, S. E., del Ángel, M., Steffen, J., Heimesaat, M. M., Dunay, I. R., & Stork, O. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.10.007 · Cited by 59
Jiang, B., Ding, T., Guo, C., Bai, X., Cao, D., Wu, X., Sha, W., Jiang, M., Wu, L., & Gao, Y. (2022) · Advanced Science · doi:10.1002/advs.202201300 · Cited by 54
An integrated cytokine and kynurenine network as the basis of neuroimmune communication
Stone, T. W., Clanchy, F. I. L., Huang, Y., Chiang, N., Darlington, L. G., & Williams, R. O. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1002004 · Cited by 60
“The deletion of fractalkine impairs CNS development and neurogenesis (Harrison et al., 1998; Cardona et al., 2006).”
BackgroundImmune cell dynamics in the CNS: Learning from the zebrafish
Oosterhof, N., Boddeke, E., & van Ham, T. J. (2015) · Glia · doi:10.1002/glia.22780 · Cited by 54
“One concept derived from recent studies on microglia is that they are under strong inhibitory control, which when lost, can lead to toxicity of microglia toward neurons (Biber et al., 2007; Cardona et al., 2006; Ransohoff and Perry, 2009).”
BackgroundAslanidis, A., Karlstetter, M., Scholz, R., Fauser, S., Neumann, H., Fried, C., Pietsch, M., & Langmann, T. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0296-6 · Cited by 54
“[6-8].”
Strobel, S., Grünblatt, E., Riederer, P., Heinsen, H., Arzberger, T., Al‐Sarraj, S., Troakes, C., Ferrer, I., & Monoranu, C. M. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-015-1369-5 · Cited by 58
“absent when neurons die or are damaged, resulting in hyper-responsive microglia (Cardona et al. 2006).”
BackgroundBollinger, J. L., Dadosky, D. T., Flurer, J. K., Rainer, I. L., Woodburn, S. C., & Wohleb, E. S. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01519-7 · Cited by 55
“relevant because CSF1R and CD11b have been shown to drive microglia-neuron interactions and synaptic remodeling [5, 30], whereas CX3CR1-signaling can either promote- or suppressaspects of microglial function [31, 32].”
BackgroundRoche, S. L., Wyse‐Jackson, A. C., Gómez‐Vicente, V., Lax, P., Ruiz‐Lopez, A. M., Byrne, A. M., Cuenca, N., & Cotter, T. G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165197 · Cited by 57
A polymorphism in CCR1/CCR3 is associated with narcolepsy
Toyoda, H., Miyagawa, T., Koike, A., Kanbayashi, T., Imanishi, A., Sagawa, Y., Kotorii, N., Kotorii, T., Hashizume, Y., Ogi, K., et al. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.05.003 · Cited by 56
“, 2000); Cx3cr1-expressing microglia have a protective effect on neurons in mouse models of neurodegeneration (Cardona et al., 2006).”
BackgroundWang, J., Pan, H.-J., Lin, Z., Xiong, C., Wei, C., Li, H., Tong, F., & Dong, X. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02138-3 · Cited by 54
Motor neuron–immune interactions: the vicious circle of ALS
Barbeito, A. G., Mesci, P., & Boillée, S. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0429-0 · Cited by 63
“For example, fraktalkine and its receptor CX3CR1, as well as CD200CD200R and SIRPα-CD47 actively maintain microglial cells in a resting state (Hoek et al. 2000; Cardona et al. 2006; Bessis et al. 2007).”
Functional Adhesiveness of the CX3CL1 Chemokine Requires Its Aggregation
Hermand, P., Pincet, F., Carvalho, S., Ansanay, H., Trinquet, E., Daoudi, M., Combadière, C., & Déterre, P. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802638200 · Cited by 56
CX3CR1 deficiency accelerates the development of retinopathy in a rodent model of type 1 diabetes
Beli, E., Dominguez, J. M., Hu, P., Thinschmidt, J. S., Caballero, S., Calzi, S. L., Luo, D., Shanmugam, S., Salazar, T. E., Duan, Y., et al. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1433-0 · Cited by 62
“In the CNS and retina, CX3CR1 is expressed by microglial cells [20].”
Role of microglia in methamphetamine-induced neurotoxicity.
Xu, E., Liu, J., Liu, H., Wang, X., & Xiong, H. (2017) · Europe PMC (PubMed Central) · Cited by 70
Trojan, E., Ślusarczyk, J., Chamera, K., Kotarska, K., Głombik, K., Kubera, M., & Basta-Kaim, A. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00779 · Cited by 52
Chemokines and Their Receptors in Central Nervous System Disease
Biber, K. P. H., de Jong, E., van Weering, H. R. J., & Boddeke, H. W. G. M. (2006) · Current Drug Targets · doi:10.2174/138945006775270196 · Cited by 53
Metadata
- Authors
- Cardona, A. E., Pioro, E. P., Sasse, M. E., Kostenko, V., Cardona, S. M., Dijkstra, I. M., Huang, D., Kidd, G., Dombrowski, S., Dutta, R., Lee, J.-C., Cook, D. N., Jung, S., Lira, S. A., Littman, D. R., & Ransohoff, R. M.
- Affiliations
- Cleveland Clinic (US)
- National Institute of Environmental Health Sciences (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Ransohoff, Richard M
- ORCID
- Venue
- Nature Neuroscience
- Published
- 2006-06-18
- Volume
- 9
- Issue
- 7
- Pages
- 917-924
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W2113107925
- Cited by
- 1,531
- References
- 39
- Citations by year
- 2026: 46 · 2025: 44 · 2024: 84 · 2023: 62 · 2022: 83 · 2021: 73 · 2020: 66 · 2019: 76 · 2018: 95 · 2017: 90 · 2016: 87 · 2015: 102 · 2014: 133 · 2013: 104 · 2012: 90
- FWCI
- 32.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (NS32151, R01NS032151)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- microglia, CX3CR1, microglial neurotoxicity, neuroinflammation, lipopolysaccharide, Parkinson's disease, amyotrophic lateral sclerosis, neuronal loss, CX3CR1 knockout mice
- MeSH terms
- CX3C Chemokine Receptor 1, Analysis of Variance, Animals, Calcium-Binding Proteins, Cells, Cultured, Central Nervous System, Disease Models, Animal, Flow Cytometry, Immunohistochemistry, Lipopolysaccharides, Mice, Inbred C57BL, Mice, Transgenic, Microfilament Proteins, Nerve Tissue Proteins, Neurons, Parkinson Disease, Cytokines, Motor Neuron Disease, Cell Death, Microglia, Receptors, Chemokine, Neurotoxicity Syndromes, Green Fluorescent Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.